文献速递骨质疏松与钙磷/甲状旁腺

WNT1和PLS3突变所致低转换型骨质疏松症中骨细胞蛋白表达改变

Osteocyte Protein Expression Is Altered in Low-Turnover Osteoporosis Caused by Mutations in WNT1 and PLS3.
PubMed 文献 · J Clin Endocrinol Metab · 2017-01-01

在WNT1或PLS3突变所致单基因骨质疏松患者中,通过免疫组化检测髂嵴样本骨细胞蛋白表达并与骨组织形态计量学比较发现,WNT1患者FGF23表达为PLS3患者的243%(P<0.01),骨髓脂肪含量WNT1高于PLS3(P=0.04),提示异常骨细胞功能可能参与单基因型骨质疏松的发病。

要点

  • WNT1突变患者骨细胞FGF23表达为PLS3患者的243%(P<0.01)。
  • WNT1患者骨髓脂肪含量高于PLS3患者(P=0.04)。
  • 磷酸化β-catenin与骨形成率呈负相关(r=-0.78,P<0.01)。

核心结论

  • 破坏WNT信号和骨细胞机械感受的突变会影响骨细胞蛋白表达,异常骨细胞功能可能在单基因型骨质疏松的发病中起作用。

研究设计与样本

  • 大学医院开展的横断面队列研究,纳入6例WNT1杂合突变患者(4例男性,年龄14至72岁)和5例PLS3杂合/半合子突变患者(4例男性,年龄9至70岁)。
  • 对髂嵴样本进行FGF23、DMP1、硬化素和磷酸化β-catenin免疫组化检测,并与骨组织形态计量学比较。

主要发现

  • WNT1患者FGF23表达为PLS3患者的243%(P<0.01)。
  • DMP1、硬化素和磷酸化β-catenin表达在两组间无差异。
  • 血清磷酸盐与FGF23表达呈负相关(r=-0.79,P=0.01),血清离子钙与硬化素表达呈负相关(r=-0.60,P=0.05)。
  • 磷酸化β-catenin表达与DMP1表达(r=-0.88,P<0.001)、类骨质体积/骨体积(r=-0.68,P=0.02)和骨形成率(r=-0.78,P<0.01)呈负相关。
  • WNT1患者骨髓脂肪含量高于PLS3患者(P=0.04)。

关键数值与推荐

  • WNT1患者FGF23表达为PLS3患者的243%(P<0.01)。
  • WNT1患者骨髓脂肪含量高于PLS3患者(P=0.04)。
  • 血清磷酸盐与FGF23表达负相关(r=-0.79,P=0.01)。
  • 血清离子钙与硬化素表达负相关(r=-0.60,P=0.05)。
  • 磷酸化β-catenin与DMP1表达负相关(r=-0.88,P<0.001),与类骨质体积/骨体积负相关(r=-0.68,P=0.02),与骨形成率负相关(r=-0.78,P<0.01)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Osteocytes express proteins that regulate bone remodeling and mineralization. OBJECTIVE: To evaluate the relationship between osteocyte-specific protein expression and bone histology in patients with monogenic osteoporosis due to wingless integration site 1 (WNT1) or plastin 3 (PLS3) mutations. DESIGN AND SETTING: Cross-sectional cohort study at a university hospital. PARTICIPANTS: Six patients (four males; ages: 14 to 72 years) with a heterozygous WNT1 mutation and five patients (four males; ages: 9 to 70 years) with a heterozygous/hemizygous PLS3 mutation. METHODS AND MAIN OUTCOME MEASURES: Immunohistochemistry was performed for fibroblast growth factor 23 (FGF23), dentin matrix protein 1 (DMP1), sclerostin, and phosphorylated (phospho-)β-catenin in iliac crest samples and compared with bone histomorphometry. RESULTS: FGF23 expression in WNT1 patients was 243% that observed in PLS3 patients (P < 0.01). DMP1, sclerostin, and phospho-β-catenin expression did not differ between groups. Serum phosphate correlated inversely with FGF23 expression (r = -0.79, P = 0.01) and serum ionized calcium correlated inversely with sclerostin expression (r = -0.60, P = 0.05). Phospho-β-catenin expression correlated inversely with DMP1 expression (r = -0.88, P < 0.001), osteoid volume/bone volume (r = -0.68, P = 0.02), and bone formation rate (r = -0.78, P < 0.01). FGF23 expression did not correlate with DMP1 expression, sclerostin expression, or bone histomorphometry. Marrow adiposity was higher in WNT1 than in PLS3 patients (P = 0.04). CONCLUSIONS: Mutations that disrupt WNT signaling and osteocytic mechanosensing affect osteocyte protein expression. Abnormal osteocyte function may play a role in the pathogenesis of monogenetic forms of osteoporosis.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Wesseling-Perry K, Mäkitie RE, Välimäki VV, et al. Osteocyte Protein Expression Is Altered in Low-Turnover Osteoporosis Caused by Mutations in WNT1 and PLS3. J Clin Endocrinol Metab. 2017. PMID: 28379384. doi:10.1210/jc.2017-00099

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。